Scientific Program - Dementia

Print
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
 
 
Alzheimer's disease & other Dementias Section Heads: Tomasz Gabryelewicz, Poland & Lefkos Middleton, UK
THURSDAY, MARCH 22, 2018 Auditorium POLIN Museum
11:00-13:00
PLENARY LECTURES - ALZHEIMER’S DISEASE (AD)
 
Chairs: Grzegorz Kozera, Poland & Weidong Le, China
11:00-11:30 How robotic technology can help in long term care of dementia patients?: Konrad Rejdak, Poland
11:30-12:00 Transmission of human AD: Virginia M. Y. Lee, USA
12:00-12:30 Pharmacological treatment of AD in the year 2028: Ezio Giacobini, Switzerland
12:30-13:00 Why have we failed to cure AD? Amos Korczyn, Israel
 
FRIDAY MARCH 23, 2018 HALL D
08:00-08:45 Meet the Expert sessions
08:45-10:55
 DEMENTIA: RISK FACTORS
Chairs: Nataliya Pryanykova, Ukraine & Ricardo Nitrini, Brazil
08:45-09:50
Does general anesthesia increase the risk of dementia?
Capsule:
Anecdotal evidence and limited case series report exacerbation of cognition following surgery under general anesthetics. Is this observation correct and should elderly individuals be warned against it?
08:45-08:55 Host: Isabel Santana, Portugal
08:55-09:15
Pro: Magda Tsolaki, Greece
09:15-09:35 Con: Lawrence Honig, USA
09:35-09:50 Discussion and Rebuttals
 
09:50-10:35
Is obstructive sleep apnea an important risk factor for dementia?
Capsule: OSA causes brain anoxia, which theoretically can exacerbate damage to the vulnerable brain. Is this of practical importance and should patients be screened for OSA?
09:50-10:00 Host: Luiza Spiru, Romania
10:00-10:20 Pro: Giancarlo Logroscino, Italy
10:20-10:40 Con: Lawrence Honig, USA
10:40-10:55 Discussion and Rebuttals
 
10:55-11:10 Coffee Break
 
11:10-13:20 ALZHEIMER'S DISEASE (AD): DIAGNOSIS AND THERAPY
Chair: Homa Ebrahimi, Iran & Federica Cioffi, The Netherlands
11:10-12:15
Can the diagnosis of AD be made solely on biomarker evidence?
Capsule: Is the presence of CSF and/or imaging biomarker evidence of abnormal brain load of amyloid and tau sufficient for the diagnosis of AD, even in the absence of cognitive decline?
11:10-11:20
Host: David Knopman, USA
11:20-11:40 Pro: Giancarlo Logroscino, Italy
11:40-12:00 Con: Lefkos Middleton, UK
12:00-12:15 Discussion and Rebuttals
 
12:15-13:20
Should agitation in AD be treated with antipsychotics?
Capsule:
Agitation in AD patients is an ominous sign, frequently leading to nursing home placement. Is it justified to treat patients with neuroleptic drugs in spite of their significant adverse effects?
12:15-12:25
Host: Tomasz Gabryelewicz, Poland
12:25-12:45 Pro: Daniel Drubach, USA
12:45-13:05 Con: Pasquale Calabrese, Switzerland
13:05-13:20 Discussion and Rebuttals
 
13:20-14:20 Industry Sponsored Symposium (Not for CME) – HALL A
 
14:20-15:05 Lunch Break & Meet the Expert sessions
 
14:20-15:05
TRANSTHYREIN (TTR) NEUROPATHY (NOT FOR CME)
Chair: Mirela Draghici, Romania & Chin-Hsiao Tseng, Taiwan
14:20-14:40 Clinical phenomenology of TTR neuropathy: Josef Finsteter, Austria
14:40-15:00 TTR neuropathy therapy: Amir Dori, Israel
15:00-15:05 Discussion
 
15:05-16:55
AD: CONCEPTS
Chair: Mee Young Park, South Korea & Mirek Brys, USA
15:05-16:00 Is amyloid deposition a non-specific manifestation of aging?
Capsule: Beta amyloid deposition is required for a pathological diagnosis of AD. Yet, many elderly people have such deposits but are cognitively normal. Can amyloid be simply a manifestation of aging, like baldness or skin wrinkles?
15:05-15:15
15:15-15:30 Pro: Panteleimon Giannakopoulos, Switzerland
15:30-15:45 Con: Marios Politis, UK
15:45-16:00 Discussion and Rebuttals
 
16:00-16:55 The term "Alzheimer's disease" should be discarded as it is impeding future research.
Capsule: For 50 years, the term AD was reserved for cases with presenile dementia, but the term has been expanded to replace the term "sentile dementia". Is this terminology shift helpful?
16:00-16:10
Host: Robert Perneczky, UK
16:10-16:25 Pro: Amos Korczyn, Israel
16:25-16:40 Con: David Knopman, USA
16:40-16:55 Discussion and Rebuttals
 
16:55-17:10
Coffee Break
 
17:10-19:00 DEMENTIA - SUGGESTED TREATMENTS
Chairs: Judith Aharon, Israel & Agnieszka Dawidowska, New Zealand
17:10-18:05 Does cognitive stimulation have value in the treatment of mild cognitive impairment (MCI) and early dementia?
Capsule:
Cognitive stimulation has been suggested as an important disease modifying strategy in people with early cognitive decline including engagement in crossword puzzles, bridge playing, and computer-based excercises. But are these really effective? What is the evidence?
17:10-17:20
Host: Dorota Religa, Sweden
17:20-17:35
Pro: Michael Geschwind, USA
17:35-17:50 Con: Roger Bullock, UK
17:50-18:05 Discussion and Rebuttals
 
18:05-19:00 Is inflammation a valid target for intervention in AD?
Capsule:
Inflammatory processes occur in any damaged tissue, and are seen in AD brains as activated microglia and astrocytes, as well as elevated cytokine and chemokine levels. Are these detrimental and should they be manipulated?
18:05-18:15
Host: Maria Barcikowska, Poland
18:15-18:30
Pro: Agneta Nordberg, Sweden
18:30-18:45 Con: Panteleimon Giannakopoulos, Switzerland
18:45-19:00 Discussion and Rebuttals
 
SUNDAY MARCH 25, 2018 HALL D
11:00-11:45 Meet the Expert sessions
 
11:00-13:00
 DEMENTIA
Chairs: Ina Buxhelaj, Albania & Michal Prendecki, Poland 
11:00-11:55
Is traumatic brain injury a risk factor for dementia?
 Capsule: In recent years, reports appeared associating moderate to severe traumatic brain injury with a greater risk to develop Alzheimer's disease or another type of dementia. Is this association true, how strong is the risk, and what is the underlying mechanism?
11:00-11:10 Host: Babak Tousi, USA
11:10-11:25
Yes: Dan Perl, USA
11:25-11:40 No: Daniel Drubach, USA
11:40-12:00 Discussion and Rebuttals
 
12:00-13:00
The clinical criteria of NPH are sensitive and predictive of response to shunting.
Capsule:
Not all patients shunted for NPH improve after surgery. Predictors for improvement are often misleading. Clinical, physiological measurement, and imaging factors can present with different pros and cons.
12:00-12:15 Host: Marek Czonsnyka, UK
12:15-12:40  Carsten Wikkelso, Sweden
12:40-13:00 Discussion and Rebuttals